Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 66   

Articles published

PFE 34.36 +0.06 (0.17%)
price chart
Merck, Pfizer Back Lawmakers Who Oppose Company Products
May 31 (Bloomberg) -- There was plenty of debate about the new health-care law in the 2010 congressional elections while little, if any, on birth control.
FDA Recommendations Bode Well For Pfizer
Pfizer (NYSE:PFE) is still transitioning itself after its best selling drug Lipitor went off patent in 2011. Also starting in July a marketing partnership between Amgen and Pfizer ends which will result in a large loss of revenue from the blockbuster ...
FDA staff question Pfizer arthritis drug benefits  Reuters
FDA Panel Recommends Tofacitinib Approval for RA  Medscape
Dow Chemical taking Pfizer space
COLLEGEVILLE —Dow Chemical Co. has finalized a long-term lease on 800,000 square feet of space at Pfizer Inc.'s campus here in what is one of the largest lease deals to be struck in the suburban office market.
Goodbye, Lipitor. Pfizer Bids a Farewell
Pfizer officials told The Wall Street Journal that the company is no longer negotiating new contracts to sell Lipitor to health plans, which are signing up to sell generic versions at far lower prices.
Pfizer, BYU settle Celebrex lawsuit for $450M
One month from the scheduled beginning of a complex eight-week trial, Brigham Young University and drug giant Pfizer Inc. settled a lawsuit Tuesday for $450 million over whether the Utah school had been cheated out of billions of dollars in royalties ...
Report: Pfizer voluntarily recalled 650000 bottles of Advil Liqui-Gels
Advil.jpg AP/FILEPfizer Inc. voluntarily recalled more than 650,000 bottles of Advil Liqui-Gels, due to an unusually strong odor.
FDA staff shoots down Pfizer rare disease drug
WASHINGTON Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease.
FDA advisory committee votes in favor of Pfizer's tafamidis meglumine  News-Medical.net
Tafamidis: FDA Shoots Down Drug For Familial Amyloid Polyneuropathy  Huffington Post
Fortune 500: Pfizer drops to No. 40 in 2012 rankings
Pfizer sign AP/FILEPfizer came in at No. 40 on the Fortune 500, the only major employer in Southwest Michigan to break the Top 50 of the annual rankings.
Merck's Frazier Says He Won't Follow Pfizer in Splitting Company
May 31 (Bloomberg) -- Merck & Co. Chief Executive Officer Ken Frazier said he doesn't plan on breaking up the company by splitting off businesses the way Pfizer Inc. and Abbott Laboratories are doing. “My philosophy is fix what is broke, don't do the ...
Amylin Said to Attract Interest From Pfizer, AstraZeneca
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter.